CUSIP: 185860202
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
477,327
-
Share change
-
+324,746
-
Total reported value
-
$1,405,000
-
Price per share
-
$2.93
-
Number of holders
-
12
-
Value change
-
+$956,142
-
Number of buys
-
9
Quarterly Holders Quick Answers
What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2017
-
Previous quarter:
Q1 2017
Recent filing periods for CUSIP 185860202:
Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q2 2017
As of 30 Jun 2017,
CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
477,327 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Virtu KCG Holdings LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, BlackRock Inc., TWO SIGMA SECURITIES, LLC, DEUTSCHE BANK AG\, THOMPSON DAVIS & CO., INC., and IFP Advisors, Inc.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.